Drugmaker backpedals on specialty status for COVID-19 drug

  • Home
  • Drugmaker backpedals on specialty status for COVID-19 drug

Drugmaker backpedals on specialty status for COVID-19 drug

Posted by The Analyst | March 26, 2020 | Politics

Facing public criticism, the maker of a promising coronavirus drug said Wednesday it will waive a special regulatory designation that could have allowed it to block competition and boost profits … Click to Continue »

Read more here:: Drugmaker backpedals on specialty status for COVID-19 drug

      

Related Blogs

No Image
Posted by The Analyst | February 24, 2021
Top board leaders resign after deadly Texas power outages
Top board leaders of Texas' embattled power grid operator said Tuesday they will resign following outrage over more than 4 million customers losing electricity last week during a deadly winter...
61 Likes
No Image
Posted by The Analyst | February 24, 2021
Asian shares slip on jitters over inflation, interest rates
Shares fell Wednesday in Asia as investors weighed the possibility that inflation might prompt central banks to adjust their ultra-low interest rate policies. Hong Kong led the decline, losing 2%...
63 Likes
No Image
Posted by The Analyst | February 24, 2021
For Senate rules arbiter, minimum wage is latest minefield
She's guided the Senate through two impeachment trials, vexed Democrats and Republicans alike with parliamentary opinions and helped rescue Electoral College certificates from a pro-Trump mob ransacking the Capitol. She...
44 Likes